首页>
外国专利>
The use of antioxidants, estrogens and antigonadotrop antiandrogenic acting for the prophylaxis and therapy of benign prostatic hyperplasia
The use of antioxidants, estrogens and antigonadotrop antiandrogenic acting for the prophylaxis and therapy of benign prostatic hyperplasia
展开▼
机译:抗氧化剂,雌激素和促性腺激素抗雄性激素在前列腺增生症的预防和治疗中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
A pharmaceutical composition comprising an anti-estrogen and an antigonadotropically effective anti-androgen, e.g., in a weight ratio of anti-estrogen to anti-androgen of essentially 2:1 to 1:10 is effective for the prophylaxis and therapy of prostate hyperplasia. Suitable anti-estrogens include, for example, tamoxifen. Antigonadotropically active anti-androgens preferably are steroids having anti-androgenic and progestational properties, e.g., cyproterone acetate.
展开▼